Navigation Links
ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
Date:9/12/2007

cal milestones and implementing important partnership programs," noted William Osgood, who was named Chief Executive Officer on July 30, 2007.

"As we indicated in our announcement on July 30, 2007, fourth quarter revenues were impacted by quality issues related to AXP disposables and lower than expected sales of our BioArchive System through our distributor GE Healthcare (GEHC). However, we maintain a very solid backlog of AXP disposables and BioArchive orders totaling $4.8 million as of today and believe we are acutely focused on addressing AXP manufacturing issues with our current provider, and bringing on-line our second source manufacturer Nipro Corporation. I am also delighted that the backlog for AXP disposables has increased significantly during the current quarter. In addition, we are working closely with GEHC to get our BioArchive sales effort back on track and we are cautiously optimistic that this quarter's BioArchive sales will exceed those of the prior quarter," he added.

Osgood said that since assuming the CEO position, he has been conducting a strategic review of the Company and implementing initiatives that will generate revenue growth and move the Company to profitability.

"ThermoGenesis possesses a number of important assets, including excellent technology, a solid market presence in the cord blood arena, strong clinical relationships and meaningful financial resources to support our initiatives. Because of factors such as increased government funding, growing appreciation for the benefits of cord blood stem cells and favorable clinical outcomes, it has become clear to me that the best approach to maximize the value of these attributes is the development of innovative products and services that address the use of adult stems cells for the treatment of disease and injury," he said.

"As a result," he continued, "going forward we will focus on growing our share of the cord blood market, positioning the Company to have a leaders
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Metavante Corp. will continue M&A activity
2. Lucigen Corp. enters global licensing agreement
3. CIO Leadership Series: Jane Durment, Marcus Corp.
4. Brady Corp. acquires Korean counterpart
5. Brady Corp. raises $137 million in public offering
6. Symphony Corp. and CareEvolution to partner
7. RedPrairie Corp. introduces new supply chain software
8. California investors acquire RedPrairie Corp.
9. Symphony Corp. moving into Fitchburg Technology Campus
10. Local group building Dane County economic development corp.
11. M & Is Metavante completes Brasfield Corp. acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... medicine company focused on the development of autologous ... at the International Society for Cellular Therapy (ISCT) ... tendinosis currently in a Phase 1/2 clinical trial.  ... from 5:30 PM to 7:00 PM local ...
(Date:5/21/2015)... Prussia, PA (PRWEB) May 21, 2015 ... O’Neill has joined the firm as senior statistician and ... 30 years of experience in the management and analysis ... biologics, pharmaceutical and chemical industries. , “We’re delighted to ... longstanding capabilities in data analytics,” said Dr. Philippe Cini, ...
(Date:5/20/2015)... and Markets ( http://www.researchandmarkets.com/research/x4b7kw/top_technologies ) has announced ... Insights" report to their offering. Technical ... the Health and Wellness sector and has identified top ... in the year 2015. The research service provides an ... wellness technologies that are anticipated to have the highest ...
(Date:5/20/2015)... DUBLIN , May 19, 2015 Research and ... addition of the "Global Cell Therapy Market Outlook ... Utilization of cell therapy in tissue and regenerative medicine ... are no other options which could help in the ... in this segment but they are unable to form ...
Breaking Biology Technology:RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Top Technologies in the Health and Wellness Industry 2015 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 2Global Cell Therapy Market Outlook 2015-2020 - 262 Cell Therapies & 13 Marketed Cell Therapies 3
... designated hitter for the Kansas City Royals, will receive the 47th ... to a Major League Baseball player who best exemplifies the honor, ... off the field. Baseball Hall of Famer Cal ... Luncheon and presentation on Feb. 1 at Safeco Field in Seattle, ...
... Jan. 5, 2012 InterMune, Inc. (NASDAQ: ITMN ... and President of InterMune, will present at the 30th Annual ... 2012, at 12:30 p.m. EST / 9:30 a.m. PST.   ... presentation, investors and other interested parties may log on to ...
... developed an ulcer on his bottom lip that began ... pathologist, and diagnosed Miller with squamous cell carcinoma (SCC).  ... cell carcinoma is the 2 nd most common ... Squamous cell cancers can occur on the skin, lips, ...
Cached Biology Technology:Royals Batter Billy Butler Named Hutch Award Winner 2Squamous Cell Cancer Responds to SPDT Therapy 2Squamous Cell Cancer Responds to SPDT Therapy 3Squamous Cell Cancer Responds to SPDT Therapy 4
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... to interact with T cells (lymph cells that play a ... do occur and demonstrated the mechanism by which they may ... responses that occur with aging and other conditions and may ... diseases. , The results of this study appear in the ...
... Why are there more species in the tropics than in ... species live in the tropics (perhaps more than half), but ... , Many researchers have hypothesized that climatic factors somehow ... a paper appearing in the November issue of The American ...
... system controls HIV during the earliest phases of infection ... key immune-system molecules called HLA Class I that have ... viral protein those molecules display to the T lymphocytes ... in the November issue of PLOS Medicine, researchers from ...
Cached Biology News:Interaction between lymph and liver cells may affect immune response 2Interaction between lymph and liver cells may affect immune response 3More species in the tropics because species have been there longer 2Early-stage immune system control of HIV may depend on inherited factors 2Early-stage immune system control of HIV may depend on inherited factors 3
... Immunogen: Synthetic peptide derived from the ... bovine Math-2. Specificity: Specific for ... Rat (positive controls: human U251 A172 ... and rat brain homogenates)Storage: Store at ...
... Interaction Kit provides an extremely fast ... isolate intact protein complexes. Unlike other ... multiple purification steps, this system takes ... Superflow Column for fast protein purification ...
poliovirus receptor-related 2 (herpesvirus entry mediator B), mRNA...
...
Biology Products: